Abstract
Myeloma nephropathy is a disorder characterized by deposition of monoclonal immunoglobulin light chains in the kidneys. The chains deposited form either amyloid fibrils or granular (amorphous) aggregates. Distinct molecular mechanisms leading to the formation of different aggregate types in kidney of patients with multiple myeloma are poorly understood. Here we describe the self-association kinetics of human monoclonal immunoglobulin light chains λ (GRY) isolated from urine of a patient with multiple myeloma. Under physiological conditions, the isolated light chain exists predominantly in a form of covalent dimer with apparent molecular mass of 50.1 kD. Spectral probe binding, analytical gel filtration, Western blot analysis, and electron microscopy indicate that GRY dimer aggregation occurs via two different pathways producing either amyloid fibrils or amorphous aggregates depending on microenvironment. Incubation of GRY (25 µM) for 4–14 days at 37°C in phosphate buffered saline (PBS), pH 7.0, or in PBS containing urea (0.8 M), pH 6.5, leads to amyloid fibril formation. Under electron microscopy, the fibrils show unbranched thread-like structures, ∼ 60–80 × 1000 Å in size, which can bind thioflavin T and Congo Red. GRY maintained in acetate buffer, pH 3.5, forms granular aggregates. The structure of GRY oligomers formed during the early stage of amyloid fibril formation (1–4 days) has been examined by means of protein cross-linking with homobifunctional reagents. These oligomers are predominantly trimers and tetramers.
Similar content being viewed by others
Abbreviations
- DSS:
-
suberic acid bis(N-hydroxysuccinimide ester)
- BS3 :
-
suberic acid bis(3-sulfo-N-hydroxysuccinimide ester)
- EDC:
-
N-ethyl-3-(3-dimethylaminopropyl)carbodiimide
- PBS:
-
phosphate buffered saline
REFERENCES
Gryazeva, I. V., Klimovich, V. B., and Pashkova, S. F. (1994) Immunologiya, 4, 31–37.
Huff, M. E., Balch, W. E., and Kelly, J. W. (2003) Curr. Opin. Struct. Biol., 13, 674–682.
Pozzi, C., and Locatelli, F. (2002) Semin. Nephrol., 22, 319–330.
Wetzel, R. (1997) in Advances in Protein Chemistry, 50, 183–236.
Laemmli, U. K. (1970) Nature, 227, 680–685.
Wall, Y., Murphy, C. L., and Solomon, A. (1999) Meth. Enzymol., 309, 204–216.
Towbin, H., Staehlin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. USA, 176, 4350–4354.
Yphantis, D. A. (1960) Ann. N. Y. Acad. Sci., 88, 586–592.
Stevens, F. J., Westholm, F. A., Solomon, A., and Schiffer, M. (1980) Proc. Natl. Acad. Sci. USA, 77, 1144–1448.
Stevens, F. J., and Schiffer, M. (1981) Biochem. J., 195, 213–219.
Myatt, E. A., Westholm, F. A., Weiss, D. T., Solomon, A., Schiffer, M., and Stevens, F. J. (1994) Proc. Natl. Acad. Sci. USA, 91, 3034–3038.
Marsh, D. Y., and Knepper, M. A. (1993) in Renal Physiology (Walker, J. M., ed.), pp. 1317–1347.
Azuma, T., Hamaguchi, K., and Migita, S. (1973) J. Biochem., 73, 1259–1269.
Liepnieks, J. J., Dwulet, F. E., and Benson, M. D. (1990) Mol. Immunol., 27, 481–485.
Khurana, R., Gillespie, J. R., Talapatra, A., Minert, L. J., Ionescu-Zanetti, C., Millett, I., and Fink, A. L. (2001) Biochemistry, 40, 3525–3535.
Davis, D. P., Gallo, G., Vogen, S. M., Dul, J. L., Sciarretta, K. L., Kumar, A., Raffen, R., Stevens, F. J., and Argon, Y. (2001) J. Mol. Biol., 313, 1021–1034.
Stevens, F. J., Myatt, E. A., Chang, C. H., Westholm, F. A., Eulitz, M., Weiss, D. T., Murphy, C., Solomon, A., and Schiffer, M. (1995) Biochemistry, 34, 10697–10702.
Souillac, P. O., Uversky, V. N., Millett, I. S., Khurana, R., Doniach, S., and Fink, A. L. (2002) J. Biol. Chem., 277, 12666–12679.
Souillac, P. O., Uversky, V. N., and Fink, A. L. (2003) Biochemistry, 42, 8094–8104.
Abraham, R. S., Charlesworth, M. C., Owen, B. A., Benson, L. M., Katzmann, J. A., Reeder, C. B., and Kyle, R. A. (2002) Clin. Chem., 48, 1805–1811.
Solling, K., Solling, J., and Lanng Nielsen, J. (1984) Acta Med. Scand., 216, 495–502.
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Biokhimiya, Vol. 70, No. 4, 2005, pp. 556–567.
Original Russian Text Copyright © 2005 by Bliznyukov, Kozmin, Vysotskaya, Golenkov, Tishchenko, Samoylovich, Klimovich.
Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM04-087, August 15, 2004.
Rights and permissions
About this article
Cite this article
Bliznyukov, O.P., Kozmin, L.D., Vysotskaya, L.L. et al. Human Immunoglobulin Light Chains λ Form Amyloid Fibrils and Granular Aggregates in Solution. Biochemistry (Moscow) 70, 458–466 (2005). https://doi.org/10.1007/s10541-005-0137-9
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/s10541-005-0137-9